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Abstract: 21 
Resistance exercise triggers a subclinical inflammatory response that plays a pivotal role 22 
in skeletal muscle regeneration. Nuclear factor-κB (NF-κB) is a stress signaling 23 
transcription factor that regulates acute and chronic states of inflammation. The classical 24 
NF-κB pathway regulates the early activation of post-exercise inflammation; however there 25 
remains scope for this complex transcription factor to play a more detailed role in post-26 
exercise muscle recovery. Sixteen volunteers completed a bout of lower body resistance 27 
exercise with the ingestion of three 400 mg doses of ibuprofen or a placebo control. 28 
Muscle biopsy samples were obtained prior to exercise and at 0, 3 and 24 h post-exercise 29 
and analysed for key markers of NF-κB activity. Phosphorylated p65 protein expression 30 
and p65 inflammatory target genes were elevated immediately post-exercise independent 31 
of the two treatments. These changes did not translate to an increase in p65 DNA binding 32 
activity. NF-κB p50 protein expression and NF-κB p50 binding activity were lower than pre-33 
exercise at 0 and 3 h post-exercise, but were elevated at 24 h post-exercise. These 34 
findings provide novel evidence that two distinct NF-κB pathways are active in skeletal 35 
muscle after resistance exercise. The initial wave of activity involving p65 resembles the 36 
classical pathway and is associated with the onset of an acute inflammatory response. The 37 
second wave of NF-κB activity comprises the p50 subunit, which has been previously 38 
shown to resolve an acute inflammatory program. The current study showed no effect of 39 
the ibuprofen treatment on markers of the NF-κB pathway, however examination of the 40 
within group effects of the exercise protocol suggests that this pathway warrants further 41 
research. 42 
43 
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Introduction: 44 
Unaccustomed resistance exercise causes skeletal muscle damage that impairs 45 
muscle function and promotes sensations of pain. The precise signaling mechanisms that 46 
initiate muscle repair following exercise-induced damage remain a topic of ongoing debate 47 
(previously reviewed by Paulsen et al. (26)). The onset of muscle damage triggers a 48 
complex interplay of intracellular events that involve myofibre injury, acute inflammation 49 
and cellular repair. At a symptomatic level, inflammation in skeletal muscle is 50 
characterised by swelling and soreness (26). Consequently post-exercise inflammation is 51 
often ascribed as a cause of delayed-onset muscle soreness (DOMS). DOMS typically 52 
occurs 2448 hours post-exercise, and is accompanied by a secondary reduction in 53 
muscle force-generating capacity. Treatment of DOMS has focused on reducing 54 
inflammation; however this may be detrimental to processes of cellular repair (36). 55 
Attenuating exercise-induced inflammation using non-steroidal anti-inflammatory drugs 56 
reduces skeletal muscle protein synthesis (34) and impairs satellite cell proliferation (23). 57 
To develop more efficacious treatments for DOMS, a better understanding of the 58 
mechanisms that govern inflammation and tissue repair in skeletal muscle after exercise is 59 
required. 60 
 61 
The nuclear factor-kappa B (NF-B) transcription factor acts as a central regulator of 62 
inflammatory signaling pathways. The NF-B family consists of five subunits, including NF-63 
B1 (p105/p50), NF-B2 (p100/p52), RelA (p65), RelB and cREL that share an amino 64 
terminus Rel homology domain. The Rel domain permits DNA binding, nuclear 65 
localization, dimerization and interaction with its own inhibitory protein IB (1, 6, 24). Under 66 
basal conditions RelA (p65), cREL and RelB subunits remain sequestered within the 67 
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cytoplasm bound to an inhibitory IB protein. The IB family that regulates NF-B includes 68 
the subunits IBβ, IBα, IBγ IBε, and Bcl-3. Unlike the Rel proteins, subunits p50 and 69 
p52 are synthesized as large precursor proteins (p105 and 100, respectively) that require 70 
proteolytic processing to permit nuclear localization. These subunits lack a REL domain, to 71 
initiate gene transcription, and hence are primarily considered as repressors of gene 72 
transcription (1, 3).  73 
 74 
Upon stimulation, the IB kinase complex (IKK) controls the degradation of IB and its 75 
precursor proteins, thereby enabling the NF-B REL subunits to control gene transcription. 76 
The IKK complex consists of two catalytic kinases IKKα and IKKβ, and a regulatory IKKγ 77 
subunit. IKKβ activates the classical NF-B signaling pathway through the phosphorylation 78 
and subsequent degradation of the inhibitor IBα (25, 40). The classical pathway typically 79 
comprises p65:p50 heterodimers, and is essential for the activation of acute inflammation 80 
by controlling the transcription on inflammatory cytokines and acute phase proteins (25, 81 
40). More recently an alternative NF-B pathway has been described, which is dependent 82 
on IKKα (30). Alternative signaling involves the activation of a secondary NF-B inducing 83 
kinase (NIK), and has been linked to the activation of both p52 and p50 subunits. The 84 
functional significance of IKKα-dependent gene expression in acute inflammation is not yet 85 
well established. However, preliminary research in rat muscle tissue suggests p50 86 
homodimers may play a crucial role in the resolution of acute inflammation (2, 17).  87 
   88 
Despite the importance of inflammation in tissue regeneration post-exercise, very little is 89 
known about how NF-B activity is regulated in skeletal muscle after acute exercise. A 90 
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transient increase in various components of the classical NF-B signaling pathway is 91 
observed in rat muscle post-exercise (9, 11, 14, 15, 31). In contrast, a decrease in NF-B 92 
DNA binding at 0 hours post-exercise with a return to near baseline 1 hour post-exercise 93 
was observed in human muscle following a traditional resistance exercise model (8). 94 
Recent work from our laboratory, using a similar resistance exercise model, demonstrated 95 
an increase in NF-B binding to the promoter region of key inflammatory cytokines at 2 96 
hours post-exercise, with a return to baseline levels at 4 hours post-exercise (37). These 97 
findings suggest that a transient NF-B response contributes to acute post-exercise 98 
inflammation.  99 
 100 
To enhance our understanding of the cellular mechanisms that regulate both the onset 101 
and resolution of post-exercise inflammation, the current study aimed to investigate 102 
changes in the activity of the subunits that comprise the classical and alternative NF-κB 103 
signaling pathways. We hypothesized that the regulation of NF-κB post-exercise would 104 
involve two distinct waves of activation. Specifically, we hypothesized that the classical 105 
NF-κB pathway, involving p65 and p50 dimers  would be activated soon after exercise 106 
during the early phases of inflammation, while the alternative pathway, comprising mainly 107 
the p50 subunit would be activated at later time points after exercise that correspond with 108 
the resolution of acute inflammation (2, 13). We also hypothesized that the administration 109 
of ibuprofen would blunt both waves of NF-κB activation, providing a potential mechanism 110 
through which anti-inflammatory medication might attenuate exercise-induced 111 
inflammation in skeletal muscle. 112 
113 
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Methods: 114 
Participants: 115 
 As previously described, sixteen healthy male subjects were recruited to participate 116 
in the study (characteristics shown in Table 1) (20). All participants completed a medical 117 
history questionnaire that was used to identify and exclude participants with a diagnosed 118 
condition or illness that prevented them from completing strenuous exercise. Exclusion 119 
criteria included participation in a lower body resistance exercise program within the last 6 120 
months to ensure a muscle damage response from the exercise stimulus, and/or chronic 121 
treatment with anti-inflammatory drugs. Current use of prescription medication or 122 
nutritional supplements also excluded subjects from participating.  123 
 124 
Ethics approval: 125 
 Prior to participation each subject received written and oral information regarding 126 
the nature of the experiment before providing written consent to participate. All procedures 127 
involved in this study were approved by the Deakin University Human Research Ethics 128 
Committee (DUHREC 2010-019). All muscle sampling procedures were performed in 129 
accordance with the Helsinki declaration. 130 
 131 
Familiarization and strength testing: 132 
 Each participant completed a familiarization session at least 7 days prior to 133 
completing the exercise trial. Participants performed repetition maximum testing to 134 
determine the experimental exercise load (80% of 1 repetition maximum (1RM)). The 135 
maximal weight each subject could lift was determined for the Smith machine-assisted 136 
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squat, the leg press, and the leg extension. These data were substituted into the validated 137 
Brzycki equation to predict 1RM for each participant (21, 38). The participants were 138 
required to abstain from any further exercise until completion of the trial.  139 
 140 
Experimental procedures: 141 
 The participants reported to the laboratory in an over-night fasted state, having 142 
abstained from caffeine, tobacco and alcohol for the preceding 24 h. Following 30 min of 143 
supine resting a pre-exercise muscle biopsy was taken. Participants then completed a 10 144 
min warm up consisting of low intensity cycling on a bicycle ergometer, and one low 145 
resistance set for each exercise at approximately 30-50% of the participants 1RM. Each 146 
participant then completed a single bout of intense resistance exercise. This session 147 
consisted of 3 sets of 8-10 repetitions of a bilateral Smith machine assisted squat, 45 148 
degree leg press and leg extension. These exercises were all performed at 80% 1RM. The 149 
exercises were performed sequentially as a circuit, with 1 min rest between each exercise, 150 
and 3 min rest between sets. We have previously used this exercise protocol and 151 
demonstrated that it activates inflammatory signaling pathways (37). Following the 152 
completion of the exercise bout, the participants rested in a supine position while muscle 153 
biopsy samples were collected. The participants returned to the laboratory the following 154 
morning in an over-night fasted state for a final muscle biopsy sample. Standardized meals 155 
were provided to participants the night preceding the trial (carbohydrate 57%, fat 22%, 156 
protein 21%), in the laboratory immediately following the exercise bout (carbohydrate 71%, 157 
fat 13%, protein 16%), as additional snacks throughout the day and an evening meal 158 
(carbohydrate 64%, fat 27%, protein 18%). 159 
  160 
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NSAID administration: 161 
 Prior to the exercise bout, the participants were randomly assigned to either the 162 
ibuprofen (NSAID) group (n = 8) or the placebo group (PLA) (n = 8). Participants in the 163 
NSAID group consumed the maximum recommended over-the-counter dose of 1200 mg 164 
of ibuprofen as three doses of 400 mg throughout the trial day. The first dose was 165 
administered upon arriving to the laboratory on the first morning of the trial, immediately 166 
prior to the first muscle biopsy sample. Participants were instructed to consume two 167 
additional doses at 2:00pm and 8:00 pm the same evening. This dosing structure was 168 
prescribed to optimise levels of circulating ibuprofen to biologically active levels throughout 169 
the course of the trial day. This protocol has previously been validated by our research 170 
group in this same group of study participants and the same NSAID administration 171 
protocol (20). Alternatively the placebo consumed a gelatin capsule containing powdered 172 
sugar, identical in appearance to the ibuprofen capsule. 173 
 174 
Sample collection: 175 
 Muscle biopsy samples were obtained under local anaesthesia (Xylocaine 1%) from 176 
the vastus lateralis muscle of either leg using the percutaneous needle biopsy technique 177 
modified to include suction (4). Samples were obtained prior to exercise, immediately 178 
following exercise and at 3 h and 24 h post-exercise. The muscle biopsy sample obtained 179 
immediately post-exercise was taken within 1-2 min of the completion of the exercise 180 
protocol, and will herein after be referred to as 0 h post-exercise. The muscle biopsy 181 
procedure has been shown to trigger a local inflammatory response (19). To minimize 182 
interference from the biopsy procedure, samples prior to exercise and at 24 h post-183 
exercise were taken from the same leg, while muscle samples obtained at 0 and 3 h post-184 
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exercise were taken from the opposite leg. Samples within the same leg were taken at 185 
least 5 cm from the previous site. We have previously reported that this technique is 186 
effective for minimizing cytokine gene expression and NF-B activity in response to 187 
muscle biopsies (37). Excised tissue was immediately immersed in liquid nitrogen and 188 
stored at 80°C until further analysis. 189 
 190 
Subjective assessment of DOMS and range of movement: 191 
 Subjective assessment of muscle soreness (DOMS) and range of movement were 192 
recorded prior to exercise and at 24 h post exercise. Subjects were asked to rate their 193 
levels of muscle soreness and range of movement on a 0-10 scale. In both instances 0 194 
was considered as the best possible result and a rating of 10 was considered to be the 195 
worst result. The data from this assessment is included in a separate manuscript which is 196 
yet to be submitted for publication. 197 
 198 
Protein extraction and quantification: 199 
Muscle samples were homogenized in ice cold RIPA buffer (50 mM Tris-HCl, pH 200 
7.4, 150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 1 mM EDTA supplemented with 201 
protease and phosphatase inhibitors including 1 mM PMSF, 1 µg/ml aprotinin, 1 µg/ml 202 
leupeptin, 1 mM Na3VO4 & 1mM NaF). The homogenate was agitated for 1 h at 4°C and 203 
centrifuged at 13,000  g at 4°C for 15 min. The resultant supernatant was removed and 204 
stored at 80°C until further analysis. Total protein concentration was determined using a 205 
BCA protein assay kit according to the manufacturer’s instruction (Pierce, Rockford, IL). 206 
Protein samples (50 µg) were denatured in loading buffer and separated by a 10% SDS-207 
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PAGE and transferred to a PVDF membrane. Membranes were blocked for 90 min at 208 
room temperature in 5% BSA/Tris buffered saline with 0.1% Tween 20 (TBST). Primary 209 
antibodies [phosphorylated NF-B p65 Ser536, total NF-B p65, NF-B p100/p52, NF-B 210 
p105/p50, NF-B cREL and β-actin (all obtained from Cell Signaling Technologies, 211 
Arundel, QLD)] were diluted to 1:1,000 in 5% BSA/TBST, applied and incubated overnight 212 
at 4°C with gentle agitation. Membranes were washed for 30 min in TBST and probed with 213 
HRP conjugated secondary antibodies diluted to 1:2,000 in 5%BSA/TBST, and incubated 214 
for 1 h at room temperature. Proteins were visualised by using Western Lighting enhanced 215 
chemiluminescence (Perkin Elmer Lifesciences, Boston, MA). Signals were captured using 216 
a Kodak Digital Image Station 2000M (model: 440CF; Eastman Kodak, Rochester, NY) 217 
and quantified by densitometry band analysis using Kodak Molecular Imaging Software 218 
(Version 4.0.5, © 1994-2005, Eastman Kodak). Phosphorylated NF-κB p65 protein was 219 
normalized to total p65 protein (Supplementary Figure 1A). NF-κB p50 protein expression 220 
was normalized to its precursor protein p105 (Supplementary Figure 1B). NF-κB p52 and 221 
cREL protein was normalized to β-actin (Supplementary Figure 1C).  222 
      223 
RNA extraction and RT-PCR: 224 
 Total cellular RNA was extracted as previously described (35) using the ToTALLY 225 
RNA Kit (Ambion, Austin, TX). RNA quality and concentration were determined using the 226 
Agilent 2100 Biolanalyzer (Agilent Technologies, Palo Alto, CA). First strand cDNA was 227 
generated from 0.5 µg total RNA using the AMV RT kit (Promega, Madison, WI). RT-PCR 228 
was performed in duplicate using the Biorad CFX384 system (Biorad, Hercules, CA), 229 
containing 5XHOT FirePol® EvaGreen Mix (Integrated Science, Sydney, NSW), forward 230 
primer, reverse primer, sterile nuclease free water and cDNA (0.125 ng/μL). Data were 231 
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analysed using a comparative critical threshold (Ct) method, where the amount of the 232 
specified target gene normalised to the amount of endogenous control, relative to the 233 
control value is given by 2-ΔΔCt. The endogenous control used in this experiment was 234 
GAPDH. The efficacy of GAPDH as an endogenous control was examined using the 235 
equation 2-ΔCt. Primers were designed using Primer Express software package version 3.0 236 
(Applied Biosystems). Gene sequences were obtained from GenBank (Table 2). Primer 237 
sequence specificity was confirmed using BLAST. A melting point dissociation curve was 238 
generated by the PCR instrument for all PCR products to confirm the presence of a single 239 
amplified product. 240 
 241 
Nuclear extraction and Transcription Factor (TF) Assay: 242 
 Nuclear and cytoplasmic proteins were extracted from 20 mg of muscle tissue using 243 
a NE-PER Nuclear and Cytoplasmic Extractions Reagents (Pierce, Rockford, IL), 244 
according to the manufacturer’s instructions. Western blot analysis probed for GAPDH, α-245 
tubulin and Lamin A was performed to ensure the nuclear extract was not contaminated by 246 
cytoplasmic proteins. A Transcription Factor Assay detecting specific transcription factor 247 
DNA binding activity was performed according to manufacturer’s instructions (Cayman 248 
Chemical, Ann Arbour, MI). Briefly, 10 µg of nuclear protein were loaded into a well 249 
containing an immobilized NF-B consensus sequence (5’GGGACTTTCC-3’) and 250 
incubated overnight at 4°C. Primary antibodies for NF-B subunits p65 and p50 were 251 
loaded in to each well and incubated at room temperature for 1 h. Each well was flushed 252 
using a diluted wash buffer for 30 min. Following a secondary 30 min wash, samples were 253 
incubated with secondary HRP-conjugated antibody for a further 1 h at room temperature. 254 
To quantify transcription factor binding, a developing solution containing a 3,3’,5,5’-255 
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Tetramethhylbenzidine (TMB) solution was added to each well and incubated for 45 min at 256 
room temperature. DNA binding was then quantified using photospectrometry with 257 
absorbance measurements taken at 450 nm using a Multiscan RC plate reader 258 
(Labsystems, Finland) and Gen5 Data Analysis Software (BioTek, Winooski, VT). 259 
 260 
Statistics: 261 
Data are expressed as means ± SEM. Prior to analysis the data displaying a lack of 262 
normality were log transformed to stabilise variance. Data were analysed using a two-way 263 
ANOVA with repeated measures for time. The sphericity adjustment was checked, and if 264 
required, a Greenhouse-Geisser epsilon to the residual degrees of freedom was applied. A 265 
data point was considered to be a statistical outlier where a z-score exceeded a pre-266 
determined threshold of ± 4.00. Where appropriate we explored within-group pair-wise 267 
comparisons between individual time-points using the Least Significant Differences of 268 
means at P < 0.05 to determine statistically significant changes (22, 29). Statistical 269 
analyses were performed using GenStat for Windows 16th Edition (VSN International, 270 
Hemel Hempstead, UK).  271 
272 
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Results: 273 
Expression of NF-B phosphorylated p65 (Ser 536) increased over time (time effect 274 
p=0.006), but this response was overall not different between the groups (interaction effect 275 
p=0.253, treatment effect p= 0.176). Nevertheless, LSD pairwise comparisons indicated 276 
that the main increase from baseline was in the placebo group at 0 h post-exercise. Within 277 
the placebo group phosphorylated p65 protein expression remained elevated at 3 h post-278 
exercise and returned to baseline by 24 h (Figure 1A). No significant changes were 279 
observed in the ibuprofen group by LSD comparisons. There was no effect of time or 280 
treatment for NF-κB total p65 (Supplementary Figure 1A).  281 
There was a trend toward a significant time  treatment interaction (p=0.057) for the 282 
protein expression of the p50 subunit, although a main effect for time (p=0.376) or 283 
treatment (p=0.865) was not achieved. Our analysis revealed a statistical outlier in the 284 
ibuprofen group at the 24 h time point. When this subject was removed from the analysis, 285 
this trend was weaker (p=0.115) (Figure 1B). LSD comparisons indicated an increase in 286 
p50 protein expression was observed at 24h post exercise in the placebo group only 287 
(Figure 1B). There were no main or interaction effects for the NF-κB p50 precursor protein 288 
p105 (Supplementary Figure 1B) or for p52 and cREL subunits (Figure 1C and Figure 1D).  289 
To determine subunit-specific DNA binding of NF-B following exercise, transcription 290 
factor binding assays were performed for p50 and p65 subunits. NF-B p50 showed a 291 
main effect for time (p=0.035), with no time  treatment interaction (p=0.851) or main effect 292 
for treatment (p =0.488) (Figure 2B). LSD comparisons identified a significant increase in 293 
p50 binding that occurred at 24 h post-exercise when compared to 0 and 3 h post-exercise 294 
within the placebo group. This coincided with the increase in p50 protein expression 295 
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(Figure 1B). No change in p65 DNA binding was observed, despite an increase in 296 
phosphorylated p65 protein expression (Figure 2B).  297 
We sought to determine whether any increase in NF-B signaling coincided with an 298 
increase in downstream inflammatory cytokines, and if the administration of ibuprofen 299 
influenced post-exercise cytokine expression. The mRNA levels of IL-6 (Figure 3A), IL-8 300 
(Figure 3B) and MCP-1 (Figure 3C) demonstrated a main effect for time (p<0.01), with the 301 
highest elevation in expression levels at 3 h post-exercise after significant increases at 0 h 302 
post-exercise. TNF-α mRNA remained unchanged after exercise (Figure 3D). COX-2 303 
mRNA showed a main effect for time (p<0.01), increasing at 0, 3 and 24 h post-exercise 304 
(Figure 3E). There were no significant interaction effects or main effects for treatment for 305 
the inflammatory cytokines or COX-2 mRNA expression. Consistently, LSD pairwise 306 
comparisons revealed similar changes over time from baseline within both groups. 307 
308 
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Discussion: 309 
The current study aimed to explore the regulation of the different NF-κB subunits 310 
following a single bout of lower body resistance exercise, and investigate the mechanism 311 
through which ibuprofen treatment may influence post-exercise inflammation. The results 312 
of this study show for the first time that an alternative NF-B signaling pathway comprising 313 
mainly p50 subunits is activated 24 h post-exercise. This pathway appears distinctly 314 
different to the activation of NF-B p65 subunit that occurs during the early stages of acute 315 
post-exercise inflammation.  316 
Phosphorylated NF-B p65 protein expression was significantly elevated in the placebo 317 
group when measured at 0 and 3 h post-exercise, and returned to baseline levels at 24 h 318 
post-exercise. These findings support those of previous research showing a post-exercise 319 
increase in key components of the classical NF-B signaling pathway in skeletal muscle, 320 
including phosphorylated NF-B p65 protein (14, 37), phosphorylated IBα protein (9, 37) 321 
and NF-B p65 DNA binding activity (12, 33). In the present study, the increase in 322 
phosphorylated NF-B p65 protein expression was not associated with an increase in p65 323 
transcription factor binding activity at 0, 3 and 24 h post-exercise. However, NF-B 324 
regulated cytokine genes including MCP-1, IL-6 and IL-8 were increased at 3 h post-325 
exercise. Previous work from our group showed an increase in NF-B p65 binding to the 326 
promoter region of genes coding for inflammatory cytokines at 2 h after traditional 327 
resistance exercise (37). This research performed a series of electrophoretic mobility shift 328 
assays that looked specifically NF-B binding to genes coding MCP-1, IL-6 and IL-8 and 329 
thus differences in the methodology may explain conflicting results. Furthermore, the 330 
discrepancy in the results between our two trials may be explained by the short half-life of 331 
NF-κB in the absence of an activating stimulus. In a HL60 cell line, the half-life of NF-κB 332 
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has been reported to be less than 30mins (10). Likewise, the inhibitory IκBα protein has a 333 
half-life of 25min in Jurkat cells (7). Therefore, in the present study, NF-B activation may 334 
have returned to resting levels by 3 h post-exercise. Research models using an extreme 335 
eccentric resistance exercise model were able to demonstrate an increase in p65 DNA 336 
binding to nuclear protein at 3 h post-exercise (12, 39). By contrast, research from Durham 337 
et al showed a decrease in NF-B DNA binding activity immediately post-exercise, which 338 
returned to baseline levels at 1 h post-exercise (8). Collectively, these findings suggest 339 
that the activation of NF-B DNA binding occurs transiently within the first few hours of 340 
exercise. Changes in NF-B activity in skeletal muscle may depend on the mode of 341 
exercise and training status of participants.  342 
This research also provides novel evidence for a potential role of NF-B p50 activation as 343 
a component of inflammation-resolution. In our initial analysis of p50 protein expression, 344 
there was a trend towards a time  group interaction effect (p=0.057) but this trend was 345 
weaker (p=0.115) after removing a statistical outlier. Despite this weaker interaction, 346 
within-group analysis by LSD comparisons revealed that p50 protein expression was 347 
elevated in the placebo group at 24 h post-exercise. Coincident with this response, p50 348 
transcription factor binding activity was highest at 24 h post-exercise. The biological 349 
significance of this delayed increase in NF-B p50 signaling during the latter stages of 350 
post-exercise recovery remains uncertain. However, in vitro work suggests that it may play 351 
a role in regulating the active resolution of acute inflammation in skeletal muscle (16, 17, 352 
30). In a model of carageenin-induced pleurisy in rats, Lawrence et al (17) provided 353 
preliminary evidence for a complex interplay between distinct NF-B signaling pathways 354 
that control an acute and transient inflammatory response. They reported that the 355 
preliminary phase of NF-B activation that occurred at 6 h was characteristic of the 356 
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classical NF-B pathway, and was associated with the onset of acute inflammation. The 357 
secondary phase was typical of the alternative NF-B pathway, comprising p50 358 
homodimers. Importantly, inhibiting this wave of activity caused a prolonged inflammatory 359 
response (17). Findings from the present study support the concept of two functionally 360 
distinct waves of NF-B activity following traditional resistance exercise. Future work is 361 
warranted to determine how this secondary wave of NF-B pathway activity influences 362 
post-exercise inflammation and skeletal muscle recovery.  363 
We used ibuprofen supplementation to investigate whether manipulating the inflammatory 364 
response to exercise through the cyclooxygenase-prostaglandin pathway alters post-365 
exercise NF-B signaling. Previous reports indicate that NF-B can function upstream of 366 
COX-2 to control transcription of this gene (25, 27). Alternatively, prostaglandin activity 367 
may also affect NF-κB (27, 28, 32). In-vitro studies demonstrate that the effect of 368 
prostaglandins on NF-B activity is specific to the class of prostaglandin. Prostaglandin E2 369 
activates the classical NF-B pathway, whereas prostaglandin A2, and prostaglandin J2 370 
and its downstream analogues can inhibit NF-B activation in response to pro-371 
inflammatory stimuli (5, 18, 28, 32). Our group recently reported changes in prostaglandins 372 
in blood serum samples after traditional resistance exercise (20). Interestingly, PGE2, 373 
PGA2 and PGD2 all peaked in expression at 2 h post-exercise. We did not find any 374 
significant time  group interaction effects for the change in p65 phosphorylation; however, 375 
LSD comparisons suggested that phosphorylated p65 expression only seemed to increase 376 
in the placebo group. Similarly the observed changes in p50 protein expression and DNA 377 
binding were only identified within the placebo group. These findings are supported by 378 
data from the study by Lawrence et al (17), which demonstrated no change in the 379 
secondary wave of NF-B DNA binding activity following the administration of an 380 
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alternative COX inhibitor, NS398, in rats with pleurisy. While these findings do not offer 381 
any conclusive evidence that ibuprofen treatment inhibits the NF-B pathway, it does 382 
provide justification to further explore this pathway as a potential mechanism through 383 
which ibuprofen treatment inhibits post-exercise inflammation. 384 
There were several limitations to the present study that need to be considered. Firstly, this 385 
analysis was run as part of a bigger study looking at the effects of ibuprofen administration 386 
on multiple components of the post-exercise inflammatory and hypertrophy response. 387 
Therefore, limited muscle sample remained to complete a more comprehensive analysis. 388 
Future research should consider the regulation of upstream markers including IKKα and 389 
IKKβ post-exercise. Furthermore, due to the invasive nature of muscle biopsies our subject 390 
population was small (n = 16).  391 
392 
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Conclusion: 393 
This research provides new insights into the regulation of NF-B following a bout of 394 
acute resistance exercise. The primary finding from this study is that NF-B activation 395 
follows a biphasic activation pattern that is subunit-specific. The first wave involves the 396 
classical NF-B p65 subunit, and corresponds with the onset of an acute inflammatory 397 
response and an increase in inflammatory cytokine gene expression. The second wave is 398 
consistent with a previously identified secondary wave of NF-B activity that involves the 399 
alternative p50 subunit. Research in alternative models of inflammation suggests that this 400 
second wave of activity may be associated with an active inflammatory resolution program. 401 
Further research into the role of p50 signaling in skeletal muscle represents a key area for 402 
future research in order to better understand the mechanisms that regulate post-exercise 403 
inflammation. Analysis of the LSD to examine pair-wise within-group differences 404 
suggested that the observed changes in both NF-B p65 and p50 were detected only 405 
within the placebo group. The complex interplay between the NF-B and the 406 
COX/prostaglandin pathway in exercise-induced muscle damage remains poorly 407 
understood, and should be a focus for future research. 408 
 409 
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 534 
Figure Captions: 535 
 536 
Figure 1: Protein expression of NF-κB subunits p65, p50, p52 and cREL. Representative 537 
Western blots for p-p65 normalized to total p65 (A), p50 normalized to p105 (B), p52 538 
normalized to β-actin (C) and cREL normalized to β-actin (D) measured in muscle biopsy 539 
samples. Data are mean arbitrary units ± SEM. * denotes statistical significance from pre 540 
exercise values in the placebo group; ^ denotes statistical significance from 24 h post-541 
exercise in the control group (p<0.05). White bars = placebo group; black bars = ibuprofen 542 
group. 543 
 544 
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Figure 2: NF-κB subunits p65 (A) and p50 (B) binding to nuclear protein. Data are mean 545 
arbitrary units ± SEM. # denotes statistical significance from 0 h post-exercise in the 546 
control group; $ denotes statistical significance from 3 h post-exercise in the control group. 547 
White bars = placebo group; black bars = ibuprofen group. 548 
 549 
Figure 3: RT-PCR analysis of NF-κB target genes IL-6 (A), IL-8 (B), MCP-1 (C), TNF-α 550 
(D) and COX-2 (E) in skeletal muscle cDNA. Data are mean arbitrary units ± SEM. * 551 
denotes statistical significance from pre exercise in the same treatment group; # denotes 552 
statistical significance from 0 h post-exercise in the same treatment group; ^ denotes 553 
statistical significance from 24 h post-exercise in the same treatment group (p<0.05). 554 
White bars = placebo group; black bars = ibuprofen group. 555 
 556 
Supplementary Figure 1: Protein expression of total NF-κB p65, NF-κB p105 and β-actin. 557 
Data are mean arbitrary units ± SEM. White bars = placebo group; black bars =ibuprofen 558 
group.  559 
 560 
Table legends: 561 
 562 
Table 1: Subject characteristics and strength testing data. Values are mean values ± 563 
SEM. No significant differences were observed between the two groups. 564 
 565 
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Table 2: Primer sequences were designed using Primer Express Software v 3.0 (Applied 566 
Biosystems) using sequences accessed through Genbank and checked for specificity 567 
using nucleotide-nucleotide BLAST search. 568 
